Fny Investment Advisers, LLC Adma Biologics, Inc. Transaction History

Fny Investment Advisers, LLC

  • $194 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 12, 2023
SELL
$3.01 - $3.87 $15,116 - $19,435
-5,022 Reduced 98.53%
75 $0
Q4 2022

Jan 10, 2023
BUY
$2.47 - $3.88 $12,404 - $19,485
5,022 Added 6696.0%
5,097 $19,000
Q3 2020

Oct 09, 2020
BUY
$2.04 - $3.74 $153 - $280
75 New
75 $0

Others Institutions Holding ADMA

# of Institutions
326
Shares Held
190M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.31B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email